Evidence map›Paper›PMID 41862419›Full record

ArticleWorld journal of surgery2026

Long-Term Outcomes After Slowly Resorbable P4HB Mesh Implantation: A Multicenter Analysis From European Registry.

Rudolf van den Berg, Marie Wieser, Manuel López-Cano, José Bueno-Lledó, Ferdinand Köckerling, Grigorios Chatzimavroudis, Constanza Gonella-Pacchiotti, Cesare Stabilini, Pablo Ortega-Deballon, Benoit Romain and 1 more

Abstract readMulticenter Study
In one paragraph

Article in World journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rudolf van den BergDepartment of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.ORCID https://orcid.org/0009-0001-8850-6166
Marie WieserDepartment of Digestive Surgery, University of Strasbourg, Hautepierre Hospital, Strasbourg, France.
Manuel López-CanoAbdominal Wall Surgery Unit, Department of General Surgery, Hospital Universitari Vall d'Hebron, Unviversitat Autònoma de Barcelona, Barcelona, Spain.
José Bueno-LledóUnit of Abdominal Wall Surgery, Department of Digestive Surgery, Hospital Universitari I Poltecnic La Fe, Fernando Abril Martorell, Valencia, Spain.
Ferdinand KöckerlingHernia Center, Vivantes Humboldt-Hospital, Academic Teaching Hospital of Charité University Medicine, Berlin, Germany.
Grigorios ChatzimavroudisComplex Hernia & Abdominal Wall Reconstruction Center, European Interbalkan Medical Center, Thessaloniki, Greece.
Constanza Gonella-PacchiottiDepartment of Surgery, S. Anna University Hospital and University of Ferrara, Ferrara, Italy.
Cesare StabiliniDepartment of Surgery, Policlinico San Martino IRCCS and Department of Surgical Sciences, University of Genoa, Genoa, Italy.
Pablo Ortega-DeballonDepartment of Digestive, Thoracic and Surgical Oncology, University Hospital, Dijon, France.
Benoit RomainDepartment of Digestive Surgery, University of Strasbourg, Hautepierre Hospital, Strasbourg, France.
PRS Group (Phasix Research Study Group)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFully resorbable biosynthetic mesh composed of poly-4-hydroxybutyrate (P4HB), have been designed for incisional hernia (IH) repair, including in contaminated surgical fields. While existing studies have demonstrated its safety and efficacy in the short term, comprehensive long-term data, particularly after complete mesh resorption, remain scarce.

methodsThis multicenter European registry analysis investigates the incidence of short- and long-term complications following IH repair with Phasix (P4HB) or Phasix ST (P4HB with hydrogel barrier; BD, Warwick, RI, USA) mesh. Adult patients from registries in France, Greece, Germany, and Spain were included and stratified using the Ventral Hernia Working Group (VHWG) classification. The primary endpoint was the incidence of long-term mesh-related complications one to five years post-implantation, after mesh resorption. Secondary endpoints included short-term complications and hernia recurrence.

resultsA total of 790 patients underwent incisional hernia repair with P4HB mesh, with a median follow-up of 38 months (IQR 36-48). Long-term follow-up beyond 24 months was available in 57% of patients. The majority of complications occur during the first 6 months. Long-term mesh-related morbidity remained low, with mesh infection occurring in 2% of patients and chronic pain in 3%-5%, even after complete mesh resorption. Rates of enterocutaneous fistula and mesh explantation were rare. Long-term complication profiles varied by hernia complexity, comorbidity burden, and mesh position, with higher ASA class associated with increased risk of mesh infection and chronic pain. The overall hernia recurrence rate was 22%, with recurrence increasing after the expected resorption period and stabilizing thereafter. Higher recurrence risk was independently associated with VHWG grade III-IV (HR of 2.55 and 2.49), obesity (HR 1.41), and intraperitoneal mesh placement (HR 2.72).

conclusionP4HB mesh demonstrated a favorable long-term safety profile after complete resorption, with low rates of mesh-related complications, even in high-risk patients. Hernia recurrence remains an important secondary outcome and is strongly influenced by patient risk factors and surgical technique. These findings support a tailored, risk-stratified approach to the use of biosynthetic meshes in IH repair.

Indexed as

Absorbable ImplantsHernia, VentralHerniorrhaphyHydroxybutyratesIncisional HerniaPolyestersPostoperative ComplicationsSurgical MeshAgedEuropeFemaleFollow-Up StudiesHumansMaleMiddle AgedRecurrenceHydroxybutyratespoly(4-hydroxybutanoate)PolyestersPhasix meshpostoperative complicationsresorbable meshventral hernia

Identifiers

PMID41862419
PMCPMC13206534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.